ReviewInsights into imaging2024
Review of strategies to reduce the contamination of the water environment by gadolinium-based contrast agents.
Review in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- ESR Essentials: gadolinium-wise MRI-practice recommendations by the European Society for Magnetic Resonance in Medicine and Biology.European radiology · 2025Guideline
- Society for Cardiovascular Magnetic Resonance recommendations toward environmentally sustainable cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025Guideline
- Predicting brain tumour enhancement from non-contrast MRI with artificial intelligence: a multicohort, retrospective, diagnostic accuracy study.The Lancet medical imaging & theranostics · 2026Article
- Can AI Detect What Is Not Injected? Evaluation of Lesion Detection in Virtual Contrast-Enhanced Breast MRI Using a Large-Scale AI Model Trained on GBCA-Enhanced Data.Tomography (Ann Arbor, Mich.) · 2026Article
- Sustainability of contrast-enhanced breast imaging: a review of current evidence.Insights into imaging · 2026Review
- Preserving Gadolinium Speciation in Environmental Waters: Establishing Hold Times and Storage Protocols for Reliable Analysis.ACS ES&T water · 2026Article
- Clinical Evaluation Before MRI Referral: Frequency and Association with Diagnostic Yield.Tomography (Ann Arbor, Mich.) · 2026Article
- Sustainability in Radiology: Position Paper and Call to Action From ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.Journal of medical imaging and radiation oncology · 2026Article
- A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cistern.European radiology · 2026Article
- Cerebral blood flow and time of exchange measurements using multi-TE blood-brain barrier arterial spin labeling MRI in IDH mutational subgroups of gliomas.Magma (New York, N.Y.) · 2026Article
- Effect of distributing urine-collection bags on contrast-material load in wastewater.European radiology · 2026Observational
- Navigation of the Clinical Implications, Interventional Challenges, and Complexities of the Circumflex Coronary Artery: A Comprehensive Review.Reviews in cardiovascular medicine · 2026Review
- Energy performance of MRI systems: on-site validation and comparison with manufacturer declarations.European radiology experimental · 2026Article
- Native T1-rho mapping for myocardial scar detection in patients with probable or confirmed coronary artery disease.Quantitative imaging in medicine and surgery · 2026Article
- Simulating dynamic tumor contrast enhancement in breast MRI using conditional generative adversarial networks.Journal of medical imaging (Bellingham, Wash.) · 2025Article
- Sustainability in radiology: position paper and call to action from ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.European radiology · 2025Article
- Gadolinium in the Environment: A Double-Edged Sword for Plant Growth and Ecosystem Stability.Metabolites · 2025Review
- Radiology AI and sustainability paradox: environmental, economic, and social dimensions.Insights into imaging · 2025Article
- Sustainability in Radiology: Position Paper and Call to Action From ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.Korean journal of radiology · 2025Review
- The GREENWATER study: patients' green sensitivity and potential recovery of injected contrast agents.European radiology · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gadolinium-based contrast agents (GBCA) are essential for diagnostic MRI examinations. GBCA are only used in small quantities on a per-patient basis; however, the acquisition of contrast-enhanced MRI examinations worldwide results in the use of many thousands of litres of GBCA per year. Data shows that these GBCA are present in sewage water, surface water, and drinking water in many regions of the world. Therefore, there is growing concern regarding the environmental impact of GBCA because of their ubiquitous presence in the aquatic environment. To address the problem of GBCA in the water system as a whole, collaboration is necessary between all stakeholders, including the producers of GBCA, medical professionals and importantly, the consumers of drinking water, i.e. the patients. This paper aims to make healthcare professionals aware of the opportunity to take the lead in making informed decisions about the use of GBCA and provides an overview of the different options for action.In this paper, we first provide a summary on the metabolism and clinical use of GBCA, then the environmental fate and observations of GBCA, followed by measures to reduce the use of GBCA. The environmental impact of GBCA can be reduced by (1) measures focusing on the application of GBCA by means of weight-based contrast volume reduction, GBCA with higher relaxivity per mmol of Gd, contrast-enhancing sequences, and post-processing; and (2) measures that reduce the waste of GBCA, including the use of bulk packaging and collecting residues of GBCA at the point of application.Critical relevance statement This review aims to make healthcare professionals aware of the environmental impact of GBCA and the opportunity for them to take the lead in making informed decisions about GBCA use and the different options to reduce its environmental burden.Key points• Gadolinium-based contrast agents are found in sources of drinking water and constitute an environmental risk.• Radiologists have a wide spectrum of options to reduce GBCA use without compromising diagnostic quality.• Radiology can become more sustainable by adopting such measures in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.